WHO ICTRP trial
[68Ga]FAPI PET/CT to detect fibroblast activity in pulmonary COVID patients with…
CTIS2024-517931-29-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-517931-29-00 |
|---|---|
| Public title | [68Ga]FAPI PET/CT to detect fibroblast activity in pulmonary COVID patients with and without long-term health problems. |
| Scientific title | LIBERATE; From Inflammation Biomarkers to Remodelling (FAPI PET/CT) towards personalized diagnosis in post-acute sequelae of COVID-19 - 19097 |
| Primary sponsor | Universitair Medisch Centrum Groningen |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): Yes Therapeutic use - (Phase IV): Yes |
| Countries | Netherlands |
| Conditions | post-acute sequelae of COVID-19;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08];Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01] |
| Interventions | Product Name: [68Ga]FAPI-46, Product Code:PRD11595253, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: |
| Registration date | Sep 24, 2024 |
| Target size | 60 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: